AMEX
0.91USD
+0.05 (+5.50%)
We have scored 8 news catalysts on Stereotaxis, Inc. (STXS) over the past 12 months. The biggest single-day move next to one of them came Nov 2, 2026, when STXS closed +6.6%: “First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT”. Coverage across the window leans positive (average ticker sentiment +0.63). Most of the impact sits in sector healthcare and forward growth expectations.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
92.1M
P/E
—
EPS
—
Beta
1.37
52W range
0.81-2.93
Day range
0.87–0.91
Open
0.88
Prev close
0.86
Volume
117.5K
Avg volume
778.8K
Dividend
0.00
IPO
2004-08-12
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Stereotaxis, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for STXS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
